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Intervention

Lessons Learned

In order to increase colon cancer screening
within our cohort, we provided clinicians at
our practice with a step-by-step guide of how
to order a FIT test. Instructions for patients
were included using a dot phrase that could be
included in patients' after visit summaries.

The primary objective of increasing colon cancer
screening within our patient cohort was
achieved. After implementing the intervention,
the number of FIT tests ordered had increased
substantially in the following months. Patients
were also more likely to complete screening.

Problem Definition
In the US, colorectal cancer (CRC) is the third
leading cause of cancer-related deaths.
According to the 2018 CDC Behavioral Risk
Factor Surveillance System survey, 68.8% of US
adults between 50 and 75 were up to date on
colorectal screening (CRCS) across all screening
modalities. In light of the COVID-19 pandemic,
screening has dropped even further and is still
50% below pre-pandemic levels. At Jefferson,
our CRCS rate is below the national average at
55.4%. Given the importance of regular
screening for CRC prevention, this is clearly
inadequate. There are several barriers to
completing an invasive screening modality like
a colonoscopy, but FIT testing may be a more
feasible option.

Results
A

B

Our results indicate that educating clinicians
about ordering FIT tests may improve screening
outcomes. This shows that some of the major
barriers in reaching screening goals were 1)
failing to discuss alternative forms of screening
with patients, 2) not being familiar with ordering
FIT tests, and 3) not effectively discussing the
steps involved in completing a FIT test with
patients. Although screening rates were low
overall, likely from fewer number of
colonoscopies performed during COVID-19, our
findings suggest that the FIT test was able to
offset the reduction in screening. The
implications of our findings are consistent with
conclusions reached in other studies conducted
during the era of COVID-19.
Future studies should aim to implement
measures to follow up with patients about
pending tests and encourage clinicians to order
more FIT tests.
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Aims For Improvement
Our aim was to increase the colonoscopy
screening rate at JHAP by 15% over a period of
eight months (September-April).
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